Literature DB >> 6281707

Biologic effects of various doses of ethinyl estradiol in postmenopausal women.

F P Mandel, F L Geola, J K Lu, P Eggena, M P Sambhi, J M Hershman, H L Judd.   

Abstract

To determine which dosage of estrogen might provide physiologic replacement while minimizing adverse effects, 20 postmenopausal women were studied before and after oral administration of ethinyl estradiol. Twenty premenopausal women studied in the early and late follicular phases of the menstrual cycle were presumed to reflect normal physiologic function. Variable responses of the different biochemical and biologic markers to the actions of ethinyl estradiol were observed. Liver protein synthesis was the most sensitive measure of the action of ethinyl estradiol. In comparing the relative potencies of ethinyl estradiol with previously reported results observed with the usage of conjugated equine estrogens, the actions of 10 micrograms ethinyl estradiol were approximately equivalent to the biologic effects of 1.25 mg conjugated estrogens. The results suggest that ethinyl estradiol is far more potent than previously believed and that the daily administration of 10 micrograms, a dose lower than currently available commercial preparations, may be adequate for relief of symptoms of vaginal atrophy and may provide protection from the occurrence of osteoporotic fractures.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6281707

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

Review 1.  Clinical opinion: the biologic and pharmacologic principles of estrogen therapy for symptomatic menopause.

Authors:  Morris Notelovitz
Journal:  MedGenMed       Date:  2006-03-28

Review 2.  Current status of postmenopausal oestrogen therapy.

Authors:  R L Young; J W Goldzieher
Journal:  Drugs       Date:  1987-02       Impact factor: 9.546

Review 3.  Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints.

Authors:  J A Balfour; R C Heel
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

4.  Transdermal estradiol substitution therapy for the induction of puberty in female hypogonadism.

Authors:  M Cisternino; K Nahoul; M Bozzola; G Grignani; G Perani; P Sampaolo; M Roger; F Severi
Journal:  J Endocrinol Invest       Date:  1991-06       Impact factor: 4.256

Review 5.  Transdermal estradiol. A review of its pharmacological profile, and therapeutic potential in the prevention of postmenopausal osteoporosis.

Authors:  J A Balfour; D McTavish
Journal:  Drugs Aging       Date:  1992 Nov-Dec       Impact factor: 3.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.